Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense oligodeoxynucleotide and ribozyme design.

J C Probst1

  • 1Wilex Biotechnology GmbH, Grillparzerstrasse 10b, Munich, D-81675, Germany. christopher.probst@wilex.de

Methods (San Diego, Calif.)
|November 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time and money: effects of no-shows at a family practice residency clinic.

Family medicine·2001
Same author

Response to complementary and alternative medicine among family medicine and other primary care physicians in South Carolina.

Journal of the South Carolina Medical Association (1975)·2001
Same author

Economic impact of hospital closure on small rural counties, 1984 to 1988: demonstration of a comparative analysis approach.

The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association·2000
Same author

Population-based survey of complementary and alternative medicine usage, patient satisfaction, and physician involvement. South Carolina Complementary Medicine Program Baseline Research Team.

Southern medical journal·2000
Same author

The relevance of community-oriented primary care for training preventive medicine residents.

Academic medicine : journal of the Association of American Medical Colleges·2000
Same author

Suppression of nidogen-1 translation by antisense targeting affects the adhesive properties of cultured astrocytes.

Glia·1999

Antisense technologies, using oligodeoxynucleotides or ribozymes, offer a powerful method to reduce specific proteins for studying gene function and potentially treating diseases. This approach targets the genetic flow from DNA to protein, impacting molecular pathways in neurobiology.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Biotechnology

Background:

  • Nucleic acid-based technologies have advanced significantly, enabling new methods for disease treatment and gene function studies.
  • Antisense strategies, particularly in neurosciences and behavioral neurobiology, hold significant promise for understanding behavior's molecular underpinnings.
  • Antisense agents impact the flow of genetic information from DNA to RNA to protein.

Purpose of the Study:

  • To describe the chemical nature and derivatives of antisense oligodeoxynucleotides.
  • To provide guidelines for antisense construction and application in research and potential therapeutics.
  • To discuss the mechanism of action, including ribozyme-mediated gene inhibition, and potential challenges.

Main Methods:

Related Experiment Videos

  • Utilizing antisense agents (oligodeoxynucleotides or ribozymes) to interfere with genetic information flow.
  • Targeting specific messenger RNA (mRNA) molecules to inhibit protein synthesis.
  • Employing chemical modifications to enhance antisense compound stability and binding affinity.

    • Main Results:

    • Antisense compounds can successfully and stably bind to target RNA molecules.
    • Binding leads to a decrease in the corresponding protein levels, enabling functional analysis or therapeutic intervention.
    • Selective and transient downregulation of target proteins aids in studying gene product function.

    Conclusions:

    • Antisense technology is a versatile tool for both fundamental research in gene function and potential therapeutic applications in various diseases.
    • Understanding the chemical properties and application guidelines of antisense agents is crucial for successful implementation.
    • Further research into antisense and ribozyme applications may overcome current challenges and expand therapeutic possibilities.